Prescription Drug Price Battles Show No Sign Of Letting Up
A pair of new cholesterol drugs is renewing a battle between pharmaceutical companies, which charge huge sums of money for new blockbuster drugs, and payers for those treatments, which include insurers, Medicare and Medicaid.